C9460 HCPCS Level II code: Injection, cangrelor, 1 mg
C9460 is the HCPCS code for “Injection, cangrelor, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9460Injection, cangrelor, 1 mg
Short description: Injection, cangrelor
HCPCS · United States
Medicare details
The indicators CMS publishes with C9460 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Added
- Jan 1, 2016
Where C9460 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9460Injection, cangrelor, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9460 mean?
C9460 is the HCPCS code for “Injection, cangrelor, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9460?
CMS lists C9460’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9460
All C codesC9454Injection, pasireotide long acting, 1 mgC9455Injection, siltuximab, 10 mgC9456Injection, isavuconazonium sulfate, 1 mgC9457Injection, sulfur hexafluoride lipid microsphere, per mlC9458Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuriesC9459Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesC9461Choline c 11, diagnostic, per study doseC9462Injection, delafloxacin, 1 mgC9463Injection, aprepitant, 1 mgC9464Injection, rolapitant, 0.5 mgC9465Hyaluronan or derivative, durolane, for intra-articular injection, per doseC9466Injection, benralizumab, 1 mg